Back to results
US 2021/0260049 A1Published application
Therapeutic Terpene Formulations
AssigneeBoomer Holdings, Inc.
InventorMark Chwajol
Life of this patent
Estimating the term…
Abstract
Therapeutic botanical terpene formulations that promote health and wellness are provided. The formulations employ a synergistic combination of beta-caryophyllene, alpha-pinene, beta-myrcene, cacao extract and black pepper extract that target and activate cannabinoid receptors of the human endocannabinoid system.
Claims16
A therapeutic composition for modulating the endocannabinoid system (“ECS”) comprising active ingredients from about 30% w/w to about 70% w/w of:
- BCP,
- anandamide, 2-AG, and epicatechin, and
- guineensine and piperine.
Dependencies are inferred from the claim text.